Literature DB >> 27210574

Urinary Incontinence Following Prostate Brachytherapy.

Michael S Leapman1, Nelson N Stone2, Stephen Mock3, Richard G Stock2, Simon J Hall4.   

Abstract

OBJECTIVE: To define the incidence, time course, and risk factors associated with the development of urinary incontinence (UI) following prostate brachytherapy.
MATERIALS AND METHODS: A total of 2461 men were identified who underwent permanent interstitial prostate brachytherapy with or without external beam radiation therapy. We examined the relationship between clinical- and treatment-related variables with the onset of UI, defined as leakage requiring pad usage, and further classified as stress (SUI) or urge (UUI) predominant, using univariate and Cox proportional hazards regression models. The changes in International Prostate Symptom Score and quality of life domains were assessed from baseline to last follow, and examined by UI status.
RESULTS: Patients were followed for a median of 6.4 years (interquartile range 4.1-9.3). UI was reported in 108 individuals (4.4%), at a median of 1.8 years (interquartile range 5 months-4.4 years): 30 with SUI and 78 with UUI. Seventy-two men (66.7%) reported using 1, 24 (22.2%) using 2, and 12 (11%) using ≥3 pads per day. On multivariate analysis, post-implantation transurethral resection of the prostate, urinary retention, external beam radiation therapy, and higher pretreatment International Prostate Symptom Score were significantly associated with the development of SUI, although transurethral resection of the prostate was the only significant risk factor associated with SUI. Men experiencing UI reported greater declines in urinary quality of life; however, no significant difference was observed between SUI and UUI.
CONCLUSION: UI occurred in 4.4% of patients following prostate brachytherapy and is more commonly urge-predominant in character. Distinct risk factors exist for the development of UUI vs SUI. Urinary leakage requiring pad usage was associated with declines in urinary QOL.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27210574     DOI: 10.1016/j.urology.2016.05.021

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Are we underestimating the rates of incontinence after prostate cancer treatment? Results from NHANES.

Authors:  Michael Daugherty; Raju Chelluri; Gennady Bratslavsky; Timothy Byler
Journal:  Int Urol Nephrol       Date:  2017-07-14       Impact factor: 2.370

Review 2.  Management of Lower Urinary Tract Symptoms after Prostate Radiation.

Authors:  Pansy Uberoi; Charlton A Smith; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2021-05-27       Impact factor: 3.092

3.  A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial.

Authors:  Carl Salembier; Ann Henry; Bradley R Pieters; Peter Hoskin
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.